分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

CHIR99021 balance TGFβ1 induced human corneal endothelial-to-mesenchymal transition to favor corneal endothelial cell proliferation

Yiran Wang, Caixia Jin, Haibin Tian, Jingying Xu, Jie Chen, Shuqin Hu, Qian Li, Lixia Lu, Qingjian Ou, Guo-tong Xu, Hongping Cui

Journal:EXPERIMENTAL EYE RESEARCH

IF:3.77

DOI:10.1016/j.exer.2022.108939

PMID:35150734

Published:2022-02-09

research field:药理学免疫学呼吸病学

Abstract

Corneal endothelial cells (CECs) play a major role in the maintenance of stromal hydration via the barrier and pump function for clear vision. Adult CECs cannot regenerate after injury. CECs cultured in vitro can undergo mitosis but may undergo corneal endothelial-to-mesenchymal transition (EnMT) and lose their endothelial characteristics. In this study, we examined the effects of CHIR99021 on transforming growth factor beta-1(TGFβ1)-induced EnMT in human CECs (hCECs) lines. CHIR99021 kept hCECs in the hexagonal shape and could downregulate the EnMT markers alpha-smooth muscle actin (α-SMA) and fibronectin (FN1), meanwhile maintained the hCECs function markers Na + /K + -ATPase and zonula occludens-1 (ZO-1) at levels comparable to those in the normal control. Interestingly, we found that the combination of CHIR99021 and TGFβ1 at appropriate concentrations would significantly promote the proliferation and migration of hCECs. These effects may be related to the inhibition of RhoA or Rac1, as well as the activation of Wnt and Erk pathway, with a calcium homeostasis . Our findings indicate that CHIR99021 inhibit EnMT and that the combination of CHIR99021 and TGFβ1 may provide new ideas for corneal endothelial regeneration and wound healing.

本文使用的Yeasen产品

购物车
客服
转染试用